Bioequivalence and Bioavailability Forum 12:57 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Distribution to erythrocytes of Methylphenidate [Bioanalytics]

posted by EKY - Thailand, 2019-01-04 03:08  - Posting: # 19727
Views: 204

According to available data that methylphenidate and its metabolites are distributed between plasma (57%) and erythrocytes (43%) in blood.

In the bioanalysis for quantification of methylphenidate in plasma, there are some hemolysis samples.

Has anyone experienced that hemolysis samples (plasma) affect the bioanalysis or the reported plasma concentrations?

Can the respective plasma concentrations from hemolysis samples be fallacious?

Best Regards,

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,032 posts in 4,059 threads, 1,299 registered users;
online 20 (1 registered, 19 guests [including 9 identified bots]).

When a distinguished but elderly scientist states that
something is possible, he is almost certainly right.
When he states that something is impossible,
he is very probably wrong.    Arthur C. Clarke

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed